0001401708-23-000214.txt : 20230905
0001401708-23-000214.hdr.sgml : 20230905
20230905163819
ACCESSION NUMBER: 0001401708-23-000214
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230901
FILED AS OF DATE: 20230905
DATE AS OF CHANGE: 20230905
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BEECHEM JOSEPH M
CENTRAL INDEX KEY: 0001576195
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35980
FILM NUMBER: 231236355
MAIL ADDRESS:
STREET 1: 530 FAIRVIEW AVENUE NORTH
STREET 2: SUITE 2000
CITY: SEATTLE
STATE: WA
ZIP: 98109
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NanoString Technologies Inc
CENTRAL INDEX KEY: 0001401708
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 200094687
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 530 FAIRVIEW AVENUE NORTH
CITY: SEATTLE
STATE: WA
ZIP: 98109
BUSINESS PHONE: 206-378-6266
MAIL ADDRESS:
STREET 1: 530 FAIRVIEW AVENUE NORTH
CITY: SEATTLE
STATE: WA
ZIP: 98109
4
1
wk-form4_1693946289.xml
FORM 4
X0508
4
2023-09-01
0
0001401708
NanoString Technologies Inc
NSTG
0001576195
BEECHEM JOSEPH M
530 FAIRVIEW AVENUE N
SEATTLE
WA
98109
0
1
0
0
SVP, Research & Development
0
Common Stock
2023-09-01
5
A
0
E
564
2.189
A
95017
D
The purchase period ended September 1, 2023 for the Offering Period (as defined in the NanoString Technologies, Inc. Employee Stock Purchase Plan ("ESPP")) that began March 1, 2023.
The reporting person is voluntarily reporting the acquisition of shares of the issuer's common stock pursuant to the ESPP, for the ESPP Purchase Period (as defined in the ESPP) of March 1, 2023 through September 1, 2023. This transaction is also exempt under Rule 16b-3(c).
In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on September 1, 2023.
/s/ Shannon Atchison, Attorney-in-fact
2023-09-05